Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

Other illness

• History of a cancer other than prostate cancer and non-melanoma skin cancer
• Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the study activities (i.e., acute psychiatric symptoms which require individual treatment)
  • For partners/close allies:
• Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the study activities (i.e., acute psychiatric symptoms which require individual treatment)

Other

• For patients:

• For patients:
• Men who meet the NCCN guidelines for low risk prostate cancer, which include all of the following:
  • Most recent Gleason score ≤ 6, or clinical stage T1a or less;
  • Most recent PSA level below 10;
  • In the most recent biopsy, had fewer than 3 positive biopsy cores (with ≤ 50% cancer in each); OR the patient's doctor discussed active surveillance as a treatment option (as documented in visit notes of the patient's medical record)
• Are able to speak, read, write and understand English well enough to provide informed consent and complete study tasks
• Has not made a treatment decision prior to consent, as per self report
• 18 years of age or older
  • For partners/close allies:
• Considered a partner/close ally to the patient in the treatment making decision, as reported by the patient
• Are able to speak, read, write and understand English well enough to provide informed consent and complete study tasks
• 18 years old or older